Tue, Mar 3, 2015, 5:05 AM EST - U.S. Markets open in 4 hrs 25 mins


% | $
Quotes you view appear here for quick access.


  • thirdmeinvestor thirdmeinvestor Mar 12, 2005 12:14 PM Flag


    Q. What differentiates MS-325 from conventional MRI imaging pharmaceuticals?
    A. Conventional MRI imaging pharmaceuticals, commonly referred to as extracellular contrast, leak rapidly from the bloodstream into the extracellular fluid. As a result, imaging must be completed within seconds, which limits their application and often requires multiple injections for visualization of multiple vascular regions. By contrast, MS-325 binds to serum albumin in the blood, providing a bright image of the blood vessels for an extended period of time, and is safely excreted by the kidneys. Thus, MS-325 enables longer data collection times, yielding a comprehensive set of high-resolution images without the technical challenge of scan timing as conventional contrast flows throughout the body. After a single injection, this intravascular imaging pharmaceutical has the potential to enable a survey of many vascular regions in one MRI examination.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.00010.0000(0.00%)Oct 25 11:34 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQMon, Mar 2, 2015 4:00 PM EST
NXP Semiconductors NV
NASDAQMon, Mar 2, 2015 4:00 PM EST